Glonghui, April 19 | Borui Pharmaceutical (688166.SH) announced that the active ingredient selamectin (veterinary) has received a CEP (European Pharmacopeia Suitability Certification) certificate issued by the European Medicines Quality Administration (“EDQM”). Xylamectin (veterinary use) is suitable for the treatment and prevention of parasitic infections in cats/dogs.
博瑞医药(688166.SH)：赛拉菌素(兽用)原料药获得欧洲CEP证书
Borui Pharmaceutical (688166.SH): Selamectin (veterinary) API obtained European CEP certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.